Trial intelligence / Profile preview

Early intervention and recovery of sexual function after rectal cancer treatment with tadalafil

2023-504592-24-00Phase 2Authorised

Sponsor
Karolinska Institutet
Start
Sep 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in sexual dysfunction, erectile dysfunction (ED) and rectal cancer comparing Tadalafil arm with Placebo / standard care arm (2 arms). Planned start Sep 2024; status: authorised.

02

Drugs

tadalafil
03

Conditions

sexual dysfunctionerectile dysfunction (ED)rectal cancer

Beyond the preview

Go deeper on 2023-504592-24-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2023-504592-24-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call